Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.10.0.1
Equity (Tables)
9 Months Ended
Sep. 30, 2018
Stockholders' Equity Note [Abstract]  
Schedule of Common Stock Transactions

The following table illustrates the common stock transactions for the nine months ended September 30, 2018:

 

    Preferred     Common  
Category   Shares     Shares  
Cash, common shares     0       1,083,671  
Services     0       1,953,134  
Services, authorized but not issued     0       43,602  
                 
Patents     0       200,000  
Cash, common shares purchased but not issued as of
the statement date
    0       1,019,600  
Total     0       4,300,007  

Schedule of Issuance of Warrants

      Warrants Issued     Exercise Price     Expiration Date
May 11, 2017       6,038,462     $ 0.50     May 11, 2020
February 23, 2018       232,334     $ 6.00     February 23, 2021
October 5, 2018       537,800     $ 2.50     October 5, 2018
Total       6,808,596              

Schedule of Effects of Changes in Ownership Interest

The following schedule discloses the effects of changes in the Company’s ownership interest in its subsidiaries on the Company’s equity:

 

    For the Three Months 
Ending 
September 30, 2018
    For the Nine Months 
Ending 
September 30, 2018
 
Net loss attributable to GSRX Industries Inc.   $ (1,655,745 )   $ (13,647,636 )
Decrease in additional paid in capital related to Recognition of Non-Controlling Interest Attributable to Spirulinex     (622,721 )     (622,721 )
Change in net loss attributable to GSRX Industries Inc. and transfers to Non-Controlling Interest   $ (2,318,466 )   $ (14,310,357 )